Renal handling of adipokines

Hitomi Kataoka, Kumar Sharma

Research output: Chapter in Book/Report/Conference proceedingChapter

11 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) is now considered as one of the strongest risk factors for all cause mortality and cardiovascular events. However, the link between CKD and systemic events is unclear. The role of the kidney is primarily considered a target organ during the development of obesity as altered production of adipokines from visceral adipocytes, however, it should also be recognized that the kidney itself could alter the clearance and production of adiopokines. In this chapter, we provide a discussion of renal handling of a variety of adipokines. Specifically, there is a growing body of data supporting a major role for the kidney in clearance of insulin, leptin, and TGF-β. In addition, plasminogen activator inhibitor-1, vascular endothelial growth factor, angiotensin II, and resistin may also be altered by the kidney. The mechanistic regulation of renal handling by the kidney of a variety of circulating adipokines, however is poorly defined. We conclude that the kidney has pivotal roles in the regulation of adipokines and that altered renal handling of adipokines may contribute to the imbalance of factors that ultimately lead to progressive cardiovascular and systemic disease.

Original languageEnglish
Title of host publicationObesity and the Kidney
EditorsG. Wolf
Pages91-105
Number of pages15
DOIs
Publication statusPublished - Sep 4 2006
Externally publishedYes

Publication series

NameContributions to Nephrology
Volume151
ISSN (Print)0302-5144

    Fingerprint

ASJC Scopus subject areas

  • Nephrology

Cite this

Kataoka, H., & Sharma, K. (2006). Renal handling of adipokines. In G. Wolf (Ed.), Obesity and the Kidney (pp. 91-105). (Contributions to Nephrology; Vol. 151). https://doi.org/10.1159/000095321